Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling.

Journal of Cardiovascular Pharmacology and Therapeutics
Vasileios SousonisKonstantinos Malliaras

Abstract

Allogeneic cardiosphere-derived cells (CDCs) exert cardioprotective effects when administered intracoronarily after reperfusion in animal models of acute myocardial infarction (AMI). The "no-reflow" phenomenon develops rapidly post-reperfusion and may undermine the efficacy of cell therapy, due to poor cell delivery in areas of microvascular obstruction (MVO). We hypothesized that CDC-induced cardioprotection would be enhanced by cell administration prior to reperfusion, when microvasculature is still relatively intact, to facilitate widespread cell delivery within the ischemic area. We studied 81 farm pigs; 55 completed the specified protocols. A dose-optimization study in infarcted pigs demonstrated that the doses of 5 million and 10 million CDCs are the maximum safe doses that can be administered intracoronarily at 5 minutes prior to and at 5 minutes post-reperfusion, respectively, without aggravating MVO. Quantification of acute cell retention by polymerase chain reaction demonstrated that cell delivery prior to reperfusion resulted in higher cardiac cell retention compared to delivery post-reperfusion. We then performed a randomized, placebo-controlled study to assess the long-term efficacy of intracoronary infusion of 5 m...Continue Reading

References

May 11, 1976·The Journal of Clinical Investigation·F R CobbJ C Greenfield
Dec 1, 1974·The Journal of Clinical Investigation·R A KlonerR B Jennings
Mar 1, 1993·Journal of the American College of Cardiology·R J HarimanH S Loeb
Feb 6, 2002·Circulation·Shereif H Rezkalla, Robert A Kloner
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Thorsten Reffelmann, Robert A Kloner
Oct 9, 2004·Circulation Research·Elisa MessinaAlessandro Giacomello
Oct 19, 2004·Journal of the American College of Cardiology·Raymond J GibbonsAllan S Jaffe
Dec 17, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Helge MöllmannUlrich Laufs
Mar 31, 2011·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Michael BoniosM Roselle Abraham
Jun 18, 2014·Stem Cell Reports·Ahmed Gamal-Eldin IbrahimEduardo Marbán
Jan 3, 2015·The American Journal of Medicine·Sami M A AlnasserUNKNOWN GRACE Investigators
Jul 28, 2015·The Journal of Clinical Investigation·Geoffrey de CoutoEduardo Marbán
Jul 22, 2016·JAMA Cardiology·Yariv GerberVéronique L Roger

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genetic modification

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.